Johnson & Johnson is scheduled to report third-quarter 2026 results on October 13, 2026, with published consensus EPS estimates of approximately $3.02-$3.04.
Korean translation
존슨앤드존슨은 2026년 10월 13일 3분기 실적을 발표할 예정이며, 공개된 컨센서스 EPS는 약 3.02~3.04달러임.
Johnson & Johnson is scheduled to report third-quarter 2026 results on October 13, 2026, with published consensus EPS estimates of approximately $3.02-$3.04.
Korean translation
존슨앤드존슨은 2026년 10월 13일 3분기 실적을 발표할 예정이며, 공개된 컨센서스 EPS는 약 3.02~3.04달러임.